188 related articles for article (PubMed ID: 9600553)
1. Botulinum toxin A compared with stretching casts in the treatment of spastic equinus: a randomised prospective trial.
Corry IS; Cosgrove AP; Duffy CM; McNeill S; Taylor TC; Graham HK
J Pediatr Orthop; 1998; 18(3):304-11. PubMed ID: 9600553
[TBL] [Abstract][Full Text] [Related]
2. [Botulinum A in the treatment of equinus dynamic spasticity in children with cerebral palsy. Preliminary study].
Mousny M; Allington N
Rev Chir Orthop Reparatrice Appar Mot; 1999 May; 85(2):156-63. PubMed ID: 10392416
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin type A and dynamic equinus in children with cerebral palsy: new indication. Better than repeat casts.
Prescrire Int; 2001 Feb; 10(51):12-4. PubMed ID: 11503850
[TBL] [Abstract][Full Text] [Related]
4. A pilot study of delayed versus immediate serial casting after botulinum toxin injection for partially reducible spastic equinus.
Newman CJ; Kennedy A; Walsh M; O'Brien T; Lynch B; Hensey O
J Pediatr Orthop; 2007 Dec; 27(8):882-5. PubMed ID: 18209608
[TBL] [Abstract][Full Text] [Related]
5. Comparing botulinum toxin A with casting for treatment of dynamic equinus in children with cerebral palsy.
Ackman JD; Russman BS; Thomas SS; Buckon CE; Sussman MD; Masso P; Sanders J; D'Astous J; Aiona MD;
Dev Med Child Neurol; 2005 Sep; 47(9):620-7. PubMed ID: 16138670
[TBL] [Abstract][Full Text] [Related]
6. Kinematic and kinetic evaluation of the ankle after intramuscular injection of botulinum toxin A in children with cerebral palsy.
Zürcher AW; Molenaers G; Desloovere K; Fabry G
Acta Orthop Belg; 2001 Dec; 67(5):475-80. PubMed ID: 11822078
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: a randomized, double-blind, placebo-controlled trial. BOTOX Study Group.
Koman LA; Mooney JF; Smith BP; Walker F; Leon JM
J Pediatr Orthop; 2000; 20(1):108-15. PubMed ID: 10641699
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin type A for the treatment of the spastic equinus foot in cerebral palsy.
Cardoso ES; Rodrigues BM; Barroso M; Menezes CJ; Lucena RS; Nora DB; Melo A
Pediatr Neurol; 2006 Feb; 34(2):106-9. PubMed ID: 16458821
[TBL] [Abstract][Full Text] [Related]
9. The effect of injections of botulinum toxin type A combined with casting on the equinus gait of children with cerebral palsy.
Hayek S; Gershon A; Wientroub S; Yizhar Z
J Bone Joint Surg Br; 2010 Aug; 92(8):1152-9. PubMed ID: 20675764
[TBL] [Abstract][Full Text] [Related]
10. Short-term effects of "botulinum toxin a" as treatment for children with cerebral palsy: kinematic and kinetic aspects at the ankle joint.
Galli M; Crivellini M; Santambrogio GC; Fazzi E; Motta F
Funct Neurol; 2001; 16(4):317-23. PubMed ID: 11853322
[TBL] [Abstract][Full Text] [Related]
11. Influence of equinus treatments on the vertical displacement of the body's centre of mass in children with cerebral palsy.
Massaad F; van den Hecke A; Renders A; Detrembleur C
Dev Med Child Neurol; 2006 Oct; 48(10):813-8. PubMed ID: 16978460
[TBL] [Abstract][Full Text] [Related]
12. Assessment protocol for serial casting after botulinum toxin a injections to treat equinus gait.
Kelly B; MacKay-Lyons MJ; Berryman S; Hyndman J; Wood E
Pediatr Phys Ther; 2008; 20(3):233-41. PubMed ID: 18703960
[TBL] [Abstract][Full Text] [Related]
13. Determinants of responsiveness to botulinum toxin, casting, and bracing in the treatment of spastic equinus in children with cerebral palsy.
Yap R; Majnemer A; Benaroch T; Cantin MA
Dev Med Child Neurol; 2010 Feb; 52(2):186-93. PubMed ID: 20412253
[TBL] [Abstract][Full Text] [Related]
14. Treatment of spastic equinus gait with botulinum toxin A: Does dose matter? Analysis of a clinical cohort.
Sätilä HK; Pietikäinen T; Lehtonen-Räty P; Koivikko M; Autti-Rämö I
Neuropediatrics; 2006 Dec; 37(6):344-9. PubMed ID: 17357036
[TBL] [Abstract][Full Text] [Related]
15. Computerized gait analysis of botulinum toxin treatment in children with cerebral palsy.
Galli M; Cimolin V; Valente EM; Crivellini M; Ialongo T; Albertini G
Disabil Rehabil; 2007 Apr; 29(8):659-64. PubMed ID: 17453987
[TBL] [Abstract][Full Text] [Related]
16. The effect of serial casting on gait in children with cerebral palsy: preliminary results from a crossover trial.
McNee AE; Will E; Lin JP; Eve LC; Gough M; Morrissey MC; Shortland AP
Gait Posture; 2007 Mar; 25(3):463-8. PubMed ID: 17008098
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin type A injections for treatment of spastic equinus in cerebral palsy: a secondary analysis of factors predictive of favorable response.
Sätilä H; Huhtala H
Am J Phys Med Rehabil; 2010 Nov; 89(11):865-72. PubMed ID: 20736816
[TBL] [Abstract][Full Text] [Related]
18. Use of a dynamic foot pressure index to monitor the effects of treatment for equinus gait in children with cerebral palsy.
Bennett D; Walsh M; O'Sullivan R; Gallagher J; O'Brien T; Newman CJ
J Pediatr Orthop; 2007; 27(3):288-94. PubMed ID: 17414011
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin type A with oral baclofen versus oral tizanidine: a nonrandomized pilot comparison in patients with cerebral palsy and spastic equinus foot deformity.
Dai AI; Wasay M; Awan S
J Child Neurol; 2008 Dec; 23(12):1464-6. PubMed ID: 19073853
[TBL] [Abstract][Full Text] [Related]
20. The influence of botulinum toxin A injections into the calf muscles on genu recurvatum in children with cerebral palsy.
Klotz MC; Wolf SI; Heitzmann D; Gantz S; Braatz F; Dreher T
Clin Orthop Relat Res; 2013 Jul; 471(7):2327-32. PubMed ID: 23463290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
